Cargando…
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand
IMPORTANCE: Randomized clinical trials in prostate cancer have reported noninferior outcomes for hypofractionated radiation therapy (HRT) compared with conventional RT (CRT); however, uptake of HRT across jurisdictions is variable. OBJECTIVE: To evaluate the use of HRT vs CRT in men with nonmetastat...
Autores principales: | Pryor, David I., Martin, Jarad M., Millar, Jeremy L., Day, Heather, Ong, Wee Loon, Skala, Marketa, FitzGerald, Liesel M., Hindson, Benjamin, Higgs, Braden, O’Callaghan, Michael E., Syed, Farhan, Hayden, Amy J., Turner, Sandra L., Papa, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561328/ https://www.ncbi.nlm.nih.gov/pubmed/34724555 http://dx.doi.org/10.1001/jamanetworkopen.2021.29647 |
Ejemplares similares
-
Risk of secondary malignancy following radiation therapy for prostate cancer
por: Tiruye, Tenaw, et al.
Publicado: (2023) -
Urban–rural prostate cancer disparities in a regional state of Australia
por: Foley, Georgea R., et al.
Publicado: (2022) -
Long‐term outcomes following post‐operative radiotherapy for Stage I/II testicular seminoma – an Australasian single‐institution experience
por: Ong, Wee Loon, et al.
Publicado: (2016) -
Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand
por: Ong, Wee Loon, et al.
Publicado: (2022) -
Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer
por: Sridharan, Swetha, et al.
Publicado: (2022)